Impact of New CLSI Guidelines on Antibiotic Susceptability Pattern

Antibiotic Susceptibility Patterns Clinical Trial

Official title: A STUDY ASSESSING THE IMPACT OF THE NEW CLSI GUIDELINES ON ANTIBIOTIC SUSCEPTABILITY TESTING PATTERNS

Status Not yet recruiting

Clinical Trial Summary

Assessing the precise MIC for the Ceftriaxone using E-test. To determine what proportion of susceptibility reports will be reclassified based on the new CLSI guidelines.Antibiotic susceptibility reports of blood cultures, urine cultures,aseptic body fluid cultures growing Enterobacteriaceae organism generated by the Phoenix machine will be obtained on a daily basis.MIC for Ceftriaxone will be noted.If the MIC is <=2 for Ceftriaxone,those cultures would be used to run an additional test - E- test.E-test gives us more precise MIC values compared to Phoenix machine.We will analyze the data collected over 2 months. We will determine the proportion of susceptibility reports reclassified based on the new CLSI guidelines.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Antibiotic Susceptibility Patterns
• Disease Susceptibility

• NCT number: NCT01352377
• Study type: Observational
• Source: University of Southern Nevada
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 2011
• Completion date: July 2011